Global Infertility Devices Market 2021 (Includes Business Impact of COVID-19)

                                          
Report updated on 11th September, 2021: Global Infertility Devices Market 2021 (Includes Business Impact of COVID-19)
Global Infertility Devices Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2030 is a recent report generated by Trusted Business Insights. The global infertility devices market report has been segmented on the basis of product type, procedure, end user, and region.
Request Covid - 19 Impact
The global Infertility Devices market size was valued at USD$600.60 billion in 2020 and is projected to reach USD$926.59 billion by 2030, and is anticipated to expand at a CAGR of 6.40% over the forecast period from 2020 to 2030.


Global Infertility Devices Market: Overview


Various types of treatment options are available for individuals suffering from infertility. These include artificial insemination procedures such as intrauterine insemination (IUI) and assisted reproductive technology (ART) procedures, including in vitro fertilization and intracytoplasmic sperm injection. IVF is the most common technique to treat infertility.


Global Infertility Devices Market: Dynamics


Increasing number of new product launches in order to treat infertility efficiently is a major factor expected to drive growth of the global market over the forecast period.

In addition, rising government funding programs for infertility is another factor expected to further fuel growth of the target market over the forecast period.

Moreover, increasing (FDA) approvals for new Over-The-Counter (OTC) devices which can help individuals to conceive children is another factor expected to boost growth of the target market over the forecast period.

Furthermore, technological advancements and new product launches by various companies are some other factors expected to propel growth of the global market over the forecast period. For instance, in February 2019, Merck Group launched two devices -Geri and Gavi, as well as Gems (a media to improve IVF) -a complete culture medium suite in India to help to treat infertility.

However, high cost of infertility treatments is a key factor expected to restrain growth of the target market over the forecast period.

Ongoing trend observed in the target market is increasing OTC ovulation and male fertility testing kits, this trend is expected to support growth of the global market over the forecast period.

Rising manufacturers focus on strategic merger and acquisition activities in order to strengthen their product portfolio and enhance t heir distribution network. For instance, in 2018, Cooper Companies, Inc. acquired The LifeGlobal Group and its affiliates of in-vitro fertilization (IVF) devices through its subsidiary Cooper Surgical in order to strengthen and improve its fertility business. In addition, rising investment for research and development activities to develop technological advanced products is another factor expected to create potential revenue opportunities for players operating in the target market over the forecast period.


Global Infertility Devices Market: Segment Analysis


Among product type segments, the equipment segment is expected to dominate in the target market over the forecast period, owing to technological advancements by various companies in this segment.

Among the procedure segments, the assisted reproductive technology segment is expected to register significant growth over the forecast period.

Among the end user segments, the fertility centers segment is expected to register significant growth over the forecast period.


Global Infertility Devices Market: Regional Analysis


The market in North America is expected to dominate in the global infertility devices market in terms of revenue over the forecast period, owing to rising obesity, increasing awareness among people toward fertility testing, and increasing prevalence of infertility across various countries in this region.

The market in Asia Pacific is expected to register significant growth in the global market over the forecast period, owing to increasing prevalence of infertility rates across Asian population.

Global Infertility Devices Market Segmentation:

Segmentation by product type:

  
Equipment
  
Imaging Systems
  
Sperm Analyzer Systems
  
Ovum Aspiration Pumps
  
Micromanipulators Systems
  
Incubators
  
Gas Analyzers
  
Laser Systems
  
Cryosystems
  
Accessories

Segmentation by procedure:

  
Assisted Reproductive Technology
  
In Vitro Fertilization
  
Intracytoplasmic Sperm Injection (ICSI)
  
Surrogacy
  
Artificial Insemination
  
Fertility Surgery
  
Other Treatments

Segmentation by end user:

  
Fertility Centers
  
Hospitals & Surgical Clinics
  
Cryobanks
  
Research Institutes


Key Market Players included in the report:


  
Art Biotech Pvt. LTD.
  
Boston IVF.
  
Carl Zeiss Meditec AG
  
Cook Group Incorporated
  
Cooper Surgical Inc.
  
Esco Micro Pte Ltd
  
Fujifilm Irvine Scientific
  
Genea Biomedx
  
Hamilton Thorne Ltd
  
Irvine Scientific
  
IVFTECH APS
  
Kitazato Corporation
  
MedGyn Products Inc.
  
Progyny Inc.
  
Rocket Medical plc
  
SOMATEX Medical Technologies GmbH
  
The Baker Company Inc.
  
The Cooper Companies Inc.
  
Thermo Fisher Scientific Inc.
  
Vitrolife AB


Below are the key development related to Infertility Devices Market in 2020 and 2021.


September 2020: MedGyn Completes Acquisition of Thomas Medical. Addition of Thomas Medicals single-use HS Catheters and womens health product lines further strengthens MedGyns portfolio of U.S. manufactured devices for healthcare professionals across the globe. MedGyn (www.MedGyn.com), a leading innovator in womens healthcare and a U.S.-based supplier of medical device products announced that through one of its subsidiaries it has completed the acquisition of Thomas Medical (www.ThomasMedical.com) from Biomerics ATL, LLC, based in Salt Lake City, Utah. Thomas Medical has a longstanding reputation that has spanned decades as a reliable brand for single-use medical devices and accessories. The Company is currently based in Indianapolis, IN and focuses on U.S.-based manufacturing for its products in order to provide reliable supply to its customers while meeting the highest quality standards. Source